These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2048577)

  • 1. Nonenzymatic glycosylation of hemoglobin and total plasmatic proteins in end-stage renal disease.
    Sabater J; Quereda C; Herrera I; Pascual J; Villafruela JJ; Ortuño J
    Am J Nephrol; 1991; 11(1):37-43. PubMed ID: 2048577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pentosidine levels in uremic patients before and after hemodialysis.
    Takahashi M; Kushida K; Ishihara C; Denda M; Inoue T
    Scand J Urol Nephrol; 1995 Jun; 29(2):131-4. PubMed ID: 7569788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific affinity-chromatographic measurement of glycated hemoglobins in uremic patients.
    Bruns DE; Lobo PI; Savory J; Wills MR
    Clin Chem; 1984 Apr; 30(4):569-71. PubMed ID: 6705201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction formula for carbamylated haemoglobin in diabetic uraemic patients.
    Hammouda AM; Mady GE
    Ann Clin Biochem; 2001 Mar; 38(Pt 2):115-9. PubMed ID: 11269750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting glycosylated hemoglobin in diabetic patients on peritoneal dialysis.
    Tzamaloukas AH
    Adv Perit Dial; 1996; 12():171-5. PubMed ID: 8865895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of micro- and macrochromatographic determinations of glycohemoglobin in diabetic patients with nephropathy.
    Saloranta C; Groop L; Ylinen K; Teramo K; Tolppanen EM; Tallgren LG
    Clin Nephrol; 1986 Apr; 25(4):186-92. PubMed ID: 3516481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of glycosylated haemoglobin in uraemia determined on ion-exchange and affinity chromatography: no increase in the rate of glycosylation.
    Wettre S; Lundberg M
    Diabetes Res; 1986 Feb; 3(2):107-10. PubMed ID: 3698480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of glycated albumin in end-stage renal failure: evidence for the principle of "physiological microalbuminuria".
    Donnelly SM
    Am J Kidney Dis; 1996 Jul; 28(1):62-6. PubMed ID: 8712223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemoglobin A1c in patients under periodic hemodialysis or continuous ambulatory peritoneal dialysis].
    Blumberg A; Marti HR
    Schweiz Med Wochenschr; 1986 Feb; 116(7):208-11. PubMed ID: 3952477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More on the increase of hemoglobin A1 in chronic renal failure: the role of acidosis.
    De Marchi S; Cecchin E; Basile A; Donadon W; Lippi U; Quaia P; Tesio F
    Nephron; 1983; 35(1):49-53. PubMed ID: 6888624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin of glycosylated hemoglobin A1 in chronic renal failure.
    De Marchi S; Cecchin E; Camurri C; Quaia P; Raimondi A; Donadon W; Lippi U; Tesio F
    Int J Artif Organs; 1983 Mar; 6(2):77-82. PubMed ID: 6840896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-chromatographic measurement of hemoglobin A1 in uremia.
    Panzetta G; Bassetto MA; Feller P; Querena M; Sandrini S; Franceschi T; Vettore L
    Clin Nephrol; 1983 Nov; 20(5):259-62. PubMed ID: 6652979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructosamines in uraemia and renal replacement therapy.
    Beardsworth SF; Vernon V; Harrison D
    Nephrol Dial Transplant; 1989; 4(8):748-9. PubMed ID: 2510086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylated haemoglobin in uraemia.
    Paisey R; Banks R; Holton R; Young K; Hopton M; White D; Hartog M
    Diabet Med; 1986; 3(5):445-8. PubMed ID: 2435450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.
    Emoto M; Tabata T; Inoue T; Nishizawa Y; Morii H
    Nephron; 1992; 61(2):181-6. PubMed ID: 1630543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical availability of serum fructosamine measurement in diabetic patients with uremia. Use as a glycemic index in uremic diabetes.
    Shoji T; Tabata T; Nishizawa Y; Kikunami K; Matsushita Y; Inoue T; Kenmotsu M; Miki T; Morii H
    Nephron; 1989; 51(3):338-43. PubMed ID: 2918945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonenzymatically glucosylated serum proteins in patients with end-stage renal disease.
    Haley RJ; Ward DM
    Am J Kidney Dis; 1986 Aug; 8(2):115-21. PubMed ID: 3740058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and dental manifestations in diabetic and nondiabetic uremic patients receiving hemodialysis.
    Chuang SF; Sung JM; Kuo SC; Huang JJ; Lee SY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jun; 99(6):689-95. PubMed ID: 15897855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum advanced glycosylation end products: a new class of uremic toxins?
    Vlassara H
    Blood Purif; 1994; 12(1):54-9. PubMed ID: 7986476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis techniques and advanced glycation end products.
    Tessitore N; Lapolla A; Aricó CN; Gammaro L; Bernich P; Fedele D
    Contrib Nephrol; 2001; (131):33-9. PubMed ID: 11125561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.